NCT02815592View on ClinicalTrials.gov

Trial of BMS-986012 in Combination With Platinum and Etoposide

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 28, 2016

Primary Completion Date

December 15, 2019

Study Completion Date

August 6, 2024

Conditions
Small Cell Lung Cancer
Interventions
DRUG

BMS-986012

DRUG

Cisplatin

DRUG

Etoposide

DRUG

Platinum

DRUG

Carboplatin

Trial Locations (4)

28041

Local Institution - 0004, Madrid

28222

Local Institution - 0003, Majadahonda - Madrid

29010

Local Institution - 0010, Málaga

08035

Local Institution - 0002, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02815592 - Trial of BMS-986012 in Combination With Platinum and Etoposide | Biotech Hunter | Biotech Hunter